Uncategorized

Infectious Testing Market Analysis to 2026: F. Hoffmann-La Roche Ltd, Abbott, bioMérieux SA, BD, Siemens Healthcare Private Limited

Global Infectious Testing Market is set to witness a substantial CAGR of 6.9% in the forecasted period of 2019-2026.The report contains data of the base year 2018 and historic year 2017. This rise in the market can be attributed due to growing demand of advanced technology and high investment in R&D activities.

Some of the major market competitors currently working in global infectious testing market are F. Hoffmann-La Roche Ltd, Abbott, bioMérieux SA, BD, Siemens Healthcare Private Limited, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories,Inc, Sysmex Corporation, Beckman Coulter, Inc, Danaher, Chembio Diagnostics Systems Inc., Cepheid, Meridian, Trinity Biotech, Sekisui Diagnostics, Quidel Corporation, MedMira, Inc., Calypte, Portland, Quest Diagnostics Incorporated, Aperiomics, Inc  and others.

Get Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-infectious-testing-market

Market Definition: Global Infectious Testing Market

Infectious disease diagnostics are the devices that are used for the detection of microorganism present in human body. Infectious diseases occur by several means such as infected food, water, air, neighborhood, from associate degree infected person, bacteria, virus and fungi. Infectious disease conditions are widespread in underdeveloped regions due to dearth of awareness of personal hygiene, less healthcare expenditures and lack of efficient physician services.

Market Drivers

  • Increasing prevalence of infectious diseases is a driver for this market
  • Rising requirement for advanced technologies in the treatment of communicable disease is driving the market growth
  • High investment in R&D activities from government and personal organizations is boosting the market growth
  • Large number of diagnostic tests carried out in hospitals is propelling the growth of the market

Market Restraints

  • Increasing prices of healthcare is restraining the market growth
  • Complicated administrative structure hampers the growth of the market
  • Stringent regulatory approval procedure for infectious diagnostic devices, emergence of molecular techniques and unfavorable reimbursement scenarios is restricting the growth of the market

Segmentation: Global Infectious Testing Market

By Product & Service

  • Assays, Kits and  Reagents
  • Instruments
  • Services & Software

By Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • DNA Microarray
  • Other Technologies

By Disease Type

  • Hepatitis
  • Human Immunodeficiency Virus (HIV)
  • Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
  • Hospital-Acquired Infections (HAIS)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Other Infectious Disease

By End User

  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Physician Offices
  • Academic/Research  Institutes
  • Other End Users

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • South America
    • Brazil
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Malaysia
    • Indonesia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific
  • Middle East and Africa
    • South Africa
    • Rest of Middle East and Africa

To Buy Complete Report Click Here @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-infectious-testing-market

Key Developments in the Market:

  • In June 2019, OraSure Technologies, Inc. a giant in point-of-care diagnostic tests and specimen collection devices took part in National HIV Testing Day in U.S. with several organizations to provide free HIV testing across the country in support of National HIV Testing Day. More than 1.1 million people are affected with HIV in U.S. With these free testing OraSure donated the OraQuick ADVANCE Rapid HIV-1/2 Antibody Test which detects antibodies to HIV-1 and HIV-2 in 20 minutes that help patients to be informed about their HIV status very quick
  • In April 2019, SpeeDx Pty, Ltd announced the agreement with Cepheid for the manufacturing of their market-leading Resistance Plus tests to use on GeneXpert System. Presence of ResistancePlus MG in a versatile cartridge runs on the GeneXpert System is a fascinating and powerful addition for the company. This agreement will help the clinics to resist information faster and to support resistance antimicrobial stewardship and more effective antibiotic treatment

Competitive Analysis:

Global infectious testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of infectious testing market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global infectious testing market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

 Get Full TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-infectious-testing-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Report Rating
Close